Unknown

Dataset Information

0

The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.


ABSTRACT: Atherosclerosis is associated with reduced vascular hydrogen sulfide (H2 S) biosynthesis. GYY4137 is a novel slow-releasing H2 S compound that may effectively mimic the time course of H2 S release in vivo. However, it is not known whether GYY4137 affects atherosclerosis.RAW 264.7 cells and human blood monocyte-derived macrophages were incubated with oxidized low density lipoprotein (ox-LDL) with/without GYY4137. ApoE(-/-) mice were fed a high-fat diet for 4 weeks and administered GYY4137 for 30 days. Lipid and atherosclerotic lesions were measured by oil red O staining. Endothelium-dependent relaxation was assessed in response to acetylcholine. Superoxide production was detected by dihydroethidium staining. Expression of mRNA and protein were evaluated by quantitative real-time PCR and Western blot.GYY4137 inhibited ox-LDL-induced foam cell formation and cholesterol esterification in cultured cells. GYY4137 decreased the expression of lectin-like ox-LDL receptor-1, iNOS, phosphorylated I?B?, NF-?B, ICAM-1, VCAM-1 and chemokines, including CXCL2, CXCR4, CXCL10 and CCL17, but increased the scavenger protein CD36, in ox-LDL-treated RAW 264.7 cells. In vivo, GYY4137 decreased aortic atherosclerotic plaque formation and partially restored aortic endothelium-dependent relaxation in apoE(-/-) mice. GYY4137 decreased ICAM-1, TNF-? and IL-6 mRNA expression as well as superoxide (O2 (-) ) generation in aorta. In addition, GYY4137 increased aortic eNOS phosphorylation and expression of PI3K, enhanced Akt Ser(473) phosphorylation and down-regulated the expression of LOX-1.GYY4137 inhibits lipid accumulation induced by ox-LDL in RAW 264.7 cells. In vivo, GYY4137 decreased vascular inflammation and oxidative stress, improved endothelial function and reduced atherosclerotic plaque formation in apoE(-/-) mice.

SUBMITTER: Liu Z 

PROVIDER: S-EPMC3753836 | biostudies-other | 2013 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.

Liu Zhen Z   Han Yi Y   Li Ling L   Lu Hui H   Meng Guoliang G   Li Xiaozhen X   Shirhan Mohammed M   Peh Meng Teng MT   Xie Liping L   Zhou Suming S   Wang Xiaowei X   Chen Qi Q   Dai Weilu W   Tan Choon-Hong CH   Pan Shiyang S   Moore Philip K PK   Ji Yong Y  

British journal of pharmacology 20130801 8


<h4>Background and purpose</h4>Atherosclerosis is associated with reduced vascular hydrogen sulfide (H2 S) biosynthesis. GYY4137 is a novel slow-releasing H2 S compound that may effectively mimic the time course of H2 S release in vivo. However, it is not known whether GYY4137 affects atherosclerosis.<h4>Experimental approach</h4>RAW 264.7 cells and human blood monocyte-derived macrophages were incubated with oxidized low density lipoprotein (ox-LDL) with/without GYY4137. ApoE(-/-) mice were fed  ...[more]

Similar Datasets

| S-EPMC3119065 | biostudies-literature
| S-EPMC2727508 | biostudies-literature
| S-EPMC6261663 | biostudies-literature
| S-EPMC5828047 | biostudies-literature
| S-EPMC6692586 | biostudies-literature
| S-EPMC6504913 | biostudies-literature
| S-EPMC5965689 | biostudies-literature
| S-EPMC6022369 | biostudies-literature
| S-EPMC8300844 | biostudies-literature
| S-EPMC4817991 | biostudies-literature